Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
Can Artificial Intelligence Help Improve Patient Understanding of Their Diagnosis? Using ChatGPT as an Interactive Chatbot for Patients With Localized Prostate Cancer, a Feasibility Study
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 19 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Biopsies
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Risk stratification in localized prostate cancer requires the patient's pre-biopsy PSA (prostate-specific antigen) value and prostate biopsy results."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether ChatGPT, an artificial intelligence (AI) chatbot, can help patients understand their prostate tissue test results and prostate cancer diagnosis. It is for adults who recently had a prostate biopsy at Cleveland Clinic’s main campus and have not yet had follow-up about their results.
The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You must be older than 18.
- You must have had a prostate biopsy at Cleveland Clinic’s main campus in the past 30 days. A biopsy removes a small tissue sample for testing.
- You must not have had follow-up about your tissue test results yet.
- You must be willing to attend an in-person visit to review your tissue test results.
- You must speak English.
- You must give informed consent, which means agreeing to join after learning about the study.
Who can't join
- You cannot join if you do not meet all the requirements listed above.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Participants must be \>18 years or age * Participants must have received a prostate biopsy at Cleveland Clinic main campus within the last 30 days, and have not received follow-up on their pathology results * Participants must be willing to attend an in-person follow-up to review their pathology * Participants must be English speaking * Participants must provide informed consent Exclusion Criteria: • Participants who do not meet the inclusion criteria, as stated above
Study sites (1)
OH
- Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute · Cleveland, OH 44195Zeyad Schwen, MD · Study contactMore trials in Cleveland